Survey							
                            
		                
		                * Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
PRACTICE GUIDELINES & CLINICAL PATHWAY ON MANAGEMENT OF DYSPEPSIA Clinical Scenario  30 year old, male  Call center representative  Epigastric pain  Denies any alarm features  Smoker; alcohol and coffee drinker  Unremarkable past medical & family history  Direct epigastric tenderness Dyspepsia Presence of 1 or more of the following symptoms (Rome III Committee):  Postprandial fullness  Early satiety  Epigastric pain or burning Assessment & Diagnosis  Based on history and physical and exam  Consider or rule out:  Dietary indiscretion  Medication induced  Cardiac disease  Gastroparesis  Hepatobiliary disorders  Other systemic disease 4 Major Causes:  Chronic peptic ulcer disease  Gastroesophageal reflux (+/- esophagitis)  Functional dyspepsia (NUD)  Malignancy Stratify Patients  Age (55 or less/ above 55)  Presence of alarm features  Family history of upper GI cancer  Unintended weight loss  GI bleeding, unexplained anemia  Progressive dyspepsia, odynophagia  Persistent vomiting  Palpable mass or lymphadenopathy  Jaundice Review of Current Literatures  Peptic ulcer is found in ~5-15% of patients  Gastric or esophageal Adenocarcinoma is identified in <2% of all patients who undergo endoscopy for dyspepsia  Upper gastrointestinal malignancy becomes more common after age 55 years Review of Current Literatures  Absence of alarm features has a negative predictive value of >97%  Chronic infection with H. pylori is associated with >80% of peptic ulcers and >1/2 of gastric cancers Patient Profile  30 year old, male  Burning epigastric pain  No alarm symptoms Empiric PPI Therapy  Empiric therapy with proton pump inhibitors for 4- 6weeks  Reassurance  No further investigations if symptoms improve  Out patient clinic follow-up Failed Empirical Therapy  No response to therapy after 7-10 days  Symptoms has not resolved after 6-8 weeks  EGD with biopsy for H. pylori  Organic disease (PUD, GERD, CA)  Treat accordingly Normal EGD (Functional Dyspepsia)  Reassurance  Lifestyle changes  Treat H. pylori if present  H. pylori regimen: PPI 40 mg 2x a day Amoxicillin 1G 2x a day Clarithromycin 500mg 2x a day (10-14 days) <55 y/o and below, no alarm features >55 y/o or w/ alarm features Empiric PPI therapy Response Failed empirical therapy EGD with biopsy for H. pylori Functional dyspepsia Reassurance Lifestyle modifications Treat H. pylori if (+) Organic disease (PUD, GERD, CA) Treat accordingly H. Pylori Follow -up  Patients who remain symptomatic after initial course of treatment should be retested 4 weeks after completion of the course  Urea breath test or stool antigen test  Some success in using previous triple therapy  Switch to another regimen: PPI+metronidazole+bismuth+tetracycline Unresponsive Functional Dyspepsia  Persistent dyspeptic symptoms  Not infected with H. pylori or have been rendered free of H. pylori  Do not respond to short course of PPI therapy  (-) negative findings on endoscopy Unresponsive Functional Dyspepsia  Reevaluate diagnosis  Consider: gastroparesis, biliary or pancreatic diseases, IBS, anxiety disorder  Limited data on use of antidepressants, prokinetic agents References  Talley NJ, Vakil NB, Moayyedi P: American Gastroenterological     Association Technical Review: Evaluation of Dyspepsia. Gasteroenterology 2005, 129:1756-1780. American Gastroenterological Association Medical Position Statement: Evaluation of Dyspepsia Gastroenterology 2005, 129:1753-1755. Lam SK, Talley NJ: Report for the 1997 Asia Pacific. Consensus Guidelines on the management of H. pylori. Journal Gasteroenterology & Hepatology 1998, 13:1-2. American Society for Gastrointestinal Endoscopy’s The role of endoscopy in dyspepsia. Gastrointestinal Endoscopy 2007, 6:1071-1075 Sleisenger and Fordtran’s Gastrointestinal and Liver Disease 8th Edition Prepared by:  Dr. Ernesto Olympia  Dr. Benjamin Benitez  Dr. Patricia Prodigalidad  Dr. William Rodriguez THANK YOU AND GOOD DAY. Test-and-Treat Approach  Test for H. pylori (Urea Breath Test or Stool Antigen Test)  Treat if (+)  Trial of PPI therapy if (-)  Do endoscopy if no symptom improvement Need for in-patient work-up and care  Severity of dyspepsia  Alarm symptoms present  Need for additional lab tests and imaging studies Possible Scenario  50 year old with CAD on ASA  Severe epigastric pain, weakness, melena  Pale Will need:  Hospital admission for medical management  Early endosocopy, CBC  Blood transfusion